Menu
GWAS Study

Multi-ancestry meta-analysis of tobacco use disorder identifies 461 potential risk genes and reveals associations with multiple health outcomes.

Toikumo S, Jennings MV, Pham BK et al.

38632388 PubMed ID
GWAS Study Type
898680 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

TS
Toikumo S
JM
Jennings MV
PB
Pham BK
LH
Lee H
MT
Mallard TT
BS
Bianchi SB
MJ
Meredith JJ
VL
Vilar-Ribó L
XH
Xu H
HA
Hatoum AS
JE
Johnson EC
PV
Pazdernik VK
JZ
Jinwala Z
PS
Pakala SR
LB
Leger BS
NM
Niarchou M
EM
Ehinmowo M
JG
Jenkins GD
BA
Batzler A
PR
Pendegraft R
PA
Palmer AA
ZH
Zhou H
BJ
Biernacka JM
CB
Coombes BJ
GJ
Gelernter J
XK
Xu K
HD
Hancock DB
CN
Cox NJ
SJ
Smoller JW
DL
Davis LK
JA
Justice AC
KH
Kranzler HR
KR
Kember RL
SS
Sanchez-Roige S
Chapter II

Abstract

Summary of the research findings

Tobacco use disorder (TUD) is the most prevalent substance use disorder in the world. Genetic factors influence smoking behaviours and although strides have been made using genome-wide association studies to identify risk variants, most variants identified have been for nicotine consumption, rather than TUD. Here we leveraged four US biobanks to perform a multi-ancestral meta-analysis of TUD (derived via electronic health records) in 653,790 individuals (495,005 European, 114,420 African American and 44,365 Latin American) and data from UK Biobank (ncombined = 898,680). We identified 88 independent risk loci; integration with functional genomic tools uncovered 461 potential risk genes, primarily expressed in the brain. TUD was genetically correlated with smoking and psychiatric traits from traditionally ascertained cohorts, externalizing behaviours in children and hundreds of medical outcomes, including HIV infection, heart disease and pain. This work furthers our biological understanding of TUD and establishes electronic health records as a source of phenotypic information for studying the genetics of TUD.

174,021 European ancestry cases, 565,874 European ancestry controls, 45,465 African American cases, 68,955 African American controls, 12,277 Latin American cases, 32,088 Latin American controls

Chapter III

Study Statistics

Key metrics and study information

898680
Total Participants
GWAS
Study Type
No
Replicated
European, African American or Afro-Caribbean, Hispanic or Latin American
Ancestry
U.K., U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.